In a significant appellate ruling closed August 19, 2024, the Canada Federal Court of Appeal dismissed AgraCity Crop & Nutrition Ltd.’s appeal of both the underlying liability decision and an associated costs decision in a patent infringement action centered on Canadian Patent CA2346021A1. The court awarded costs of both appeals to respondent UPL NA Inc., affirming the lower tribunal’s finding that AgraCity infringed claims covering selective herbicides based on substituted phenylsulphonylaminocarbonyl-triazolinone chemistry. The outcome leaves AgraCity with no remaining appellate avenue on liability and bears the full weight of adverse cost awards.

This decision carries meaningful implications for agrochemical companies, generic crop-protection formulators, and IP counsel navigating the crowded field of herbicide chemistry patents in Canada. The court’s refusal to disturb the liability finding reinforces the enforceability of composition and use patents covering substituted triazolinone herbicide actives — a class widely relevant to modern selective weed control. In-house IP teams and R&D leaders developing or commercializing post-emergent herbicide products should treat this ruling as a key FTO reference point.

Case Overview

The Parties

The Patent at Issue

Canadian Patent CA2346021A1 covers selective herbicide compositions based on substituted phenylsulphonylaminocarbonyl-triazolinone compounds. These are a specialized class of active ingredients used in crop protection to selectively target and kill certain weed species while leaving desirable crops unharmed. The patent’s key claims relate to the specific chemical formulation of these triazolinone-based actives, their preparation, and their application as herbicidal agents in agricultural settings.

• • CA2346021A1

Legal Representation

Plaintiff Counsel: Miller Thomson LLP (lead: Aiyaz A. Alibhai)
Defendant Counsel: Bereskin & Parr LLP (lead: Adam Bobker)

Litigation Timeline & Procedural History

This case was adjudicated by the Canada Federal Court of Appeal, designated under case numbers A-248-22 and A-37-23, indicating two consolidated appeal dockets — one addressing the underlying liability finding and one addressing the costs award. The Federal Court of Appeal is a national appellate court in Canada with jurisdiction over intellectual property matters, including patent infringement actions first heard at the Federal Court level. The dual-docket structure reflects the procedurally distinct but substantively linked nature of the liability and costs decisions being appealed simultaneously.

The case closed on August 19, 2024, with the appeals dismissed on the merits. Because the court disposed of both appeals in a single judgment — finding that AgraCity’s costs appeal was exclusively derivative of its liability arguments — the resolution was efficient and unambiguous. The basis of termination as an outright dismissal, rather than settlement or remand, signals that the appellate panel found no reversible error in the lower court’s liability analysis, and that the infringement findings were well-supported on the record. Costs of the appeals were awarded to UPL NA, adding further financial consequence to AgraCity’s unsuccessful challenge.

The Verdict & Legal Analysis

Outcome

The Canada Federal Court of Appeal dismissed AgraCity’s appeal of the Liability Decision finding patent infringement of CA2346021A1, and simultaneously dismissed AgraCity’s appeal of the associated Costs Decision, which the court noted was based exclusively on alleged errors in the now-affirmed liability ruling. Costs of both appeals were awarded to the respondents, UPL NA Inc. No damages quantum was determined at this appellate stage, as the appeal concerned liability and costs rather than a damages assessment.

Verdict Cause Analysis

The court’s dismissal turned on its analysis of the alleged errors raised by AgraCity in challenging the original infringement finding under the Infringement Action framework

• The appellate panel found no reversible error in the lower court’s liability decision, affirming that AgraCity’s herbicide product fell within the scope of the claims of CA2346021A1 covering substituted phenylsulphonylaminocarbonyl-triazolinone herbicides.
• AgraCity’s costs appeal was dismissed as entirely derivative — because it was predicated solely on success on the liability appeal, the failure of the latter necessarily disposed of the former.
• The court awarded costs of the appeals to UPL NA as the successful respondent, reinforcing standard Canadian appellate cost-shifting principles in patent litigation.
• The dual-docket appeal structure (A-248-22 and A-37-23) was resolved in a unified judgment, reflecting the court’s view that the two appeals shared the same factual and legal foundation.

Legal Significance

1. 1. This decision affirms the enforceability of composition and use patents covering triazolinone-based selective herbicides in Canada, signaling that appellate courts will uphold carefully constructed infringement findings in complex agrochemical patent cases.
2. 2. The court’s treatment of the derivative costs appeal — dismissing it automatically upon dismissal of the liability appeal — clarifies that in Canadian patent litigation, costs challenges must raise independent grounds of error to survive appellate review.
3. 3. The outcome strengthens UPL NA’s IP position in the Canadian agrochemical market and may deter generic or specialty formulators from attempting to commercialize herbicide products that overlap with the protected triazolinone chemistry without securing a license or conducting rigorous FTO analysis.

Strategic Takeaways

For Patent Attorneys:

• When structuring appeals of both liability and costs decisions in Canadian Federal Court patent matters, ensure the costs appeal contains independent grounds of error — courts will summarily dismiss derivative costs challenges if the underlying liability appeal fails.
• The affirmance of the infringement finding here underscores the importance of thorough claim construction and product-to-claim mapping at the trial level; appellate courts are reluctant to disturb fact-intensive infringement findings supported by adequate reasons.
• Counsel representing agrochemical defendants or appellants should anticipate that courts will award appellate costs to successful patent holders, making cost-risk assessment a central element of any appeal recommendation.
• The dual-docket consolidation in this case (A-248-22 and A-37-23) is a useful structural precedent for efficiently managing related IP appeals before the Canada Federal Court of Appeal.

For IP Professionals:

• In-house teams at agrochemical companies should use this ruling as a trigger to audit their Canadian herbicide portfolios for any products involving triazolinone-based chemistry, particularly those overlapping with the substituted phenylsulphonylaminocarbonyl-triazolinone class protected by CA2346021A1.
• The case highlights the cascading financial risk of unsuccessful patent appeals in Canada — adverse cost awards at both the trial and appellate level can substantially increase the total cost of litigation, warranting early settlement analysis for cases with weak liability arguments.

For R&D Teams:

• R&D teams developing selective herbicide formulations for the Canadian market must conduct FTO clearance specifically against triazolinone-class composition patents before advancing candidates to registration or commercialization, as this ruling confirms these patents are actively enforced.
• Design-around strategies for this chemistry class should focus on structural modifications that place the active ingredient outside the substituted phenylsulphonylaminocarbonyl-triazolinone framework — engaging patent counsel early in the discovery-to-development pipeline will reduce late-stage FTO risk.